Immunome IMNM
NASDAQ IMNM
$20.88 -0.63 (-2.93%)
As of: Oct 1, 2026 · 3:54 PM EDT

Immunome (IMNM) Net Margin (2023 - 2025)

Updated

Immunome (IMNM) recorded Net Margin of -3059.99% in FY2025, up 180.39 percentage points from -3240.38% in FY2024.

Analysis

Immunome (IMNM) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, IMNM's Net Margin was -3240.38% in FY2024 (-2478.46 pp) and -761.92% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Immunome 2.44 Bn 410.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,080.87%
Mar 31, 2025 -1,423.10%
Dec 31, 2024 -2,930.93%
Sep 30, 2024 -1,618.56%
Jun 30, 2024 -1,528.00%
Mar 31, 2024 -12,584.26%
Dec 31, 2023 -2,421.17%
Sep 30, 2023 -121.88%
Jun 30, 2023 -130.35%
Mar 31, 2023 -180.63%
API Access

Immunome Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMNM&period=max&api_key=YOUR_API_KEY